human β2-MG |
forward: 5′-tga ctt tgt cac agc cca aga ta-3′ |
reverse: 5′-aat cca aat gcg gca tct tc-3′ |
probe: FAM-tga tgc tgc tta cat gtc tcg atc cca-TAM |
human hepcidin |
forward 5′-cag gac aga gct gga gcc a -3′ |
reverse: 5′-gca gca cat ccc aca ctt tg-3′ |
probe: FAM-ctg ctg cgg ctg ctg tca tcg a-TAM |
human NOX2 |
forward: 5′- cat tca acc tct gcc acc at -3′ |
reverse: 5′- ccc cag cca aac cag aat -3′ |
probe UPL # 26 (Roche) |
human IL-1β |
forward: 5′- aaa gct tgg tga tgt ctg gtc -3′ |
reverse: 5′- gga cat gga gaa cac cac ttg -3′ |
probe UPL # 39 (Roche) |
human IL-6 |
forward: 5′- gcc cag cta tga act cct tct -3′ |
reverse: 5′- ctt ctc ctg ggg gta ctg g -3′ |
probe UPL # 68 (Roche) |
human SMAD7 |
forward: 5′- aaa cag ggg gaa cga att atc -3′ |
reverse: 5′- acc acg cac cag tgt gac -3′ |
probe UPL # 50 (Roche) |
|
forward: 5′- gga cat agg agc gca aaa gaa -3′ |
human CEBPδ |
reverse: 5′- gct tct ctc cgc agt tta gtg g -3′ |
|
probe UPL # 64 (Roche) |